Help raise funds for much-needed sarcoma research and stay active by registering to run for ANZSA at our 2024 fundraisers.
ANZSA is offering a two-year clinical research fellowship with funding available from July 2024 to undertake a significant sarcoma clinical research project. The fellowship is funded by The Tie Dye Project and The Kids Cancer Project and must have AYA and/or paediatric patient cohort involvement in the proposed study.
In 2024, there will be a change in how ANZSA members receive our newsletters throughout the year.
The 2023 ANZSA Annual General Meeting will be held on the 10th of November during our 2023 Annual Scientific Meeting. This meeting will be held as a hybrid event, with both in person and online attendance available to all.
Introducing the final ANZSA Sarcoma Research Grant Recipient for 2023, Professor Angela Hong. Prof. Hong has received funding for her project: Radiotherapy Quality Assurance for the Prospective study evaluating the treatment outcomes for localised recurrent, resectable retroperitoneal liposarcoma (ReLaPSe)
Introducing Dr. Minh-Son To, one of the four ANZSA sarcoma research grant recipients of 2023! Dr. To is receiving funding from ANZSA and Rainbows for Kate Foundation for his project, Improving the radiological evaluation of bone and soft tissue sarcomas with advanced diffusion imaging and artificial intelligence.
Introducing Dr. Carolyn Shembrey, one of the four ANZSA sarcoma research grant recipients of 2023! Dr. Shembrey has received funding from ANZSA and the Kicking Goals For Xav Foundation to fund her project, Harnessing CRISPR-Cas13 to ablate ‘undruggable’ sarcoma drivers.
Introducing Dr. Ian Parish, one of the four ANZSA sarcoma research grant recipients of 2023! Dr. Parish has received funding from ANZSA for his project, Investigating the role of CD8+ T cell tolerance within the tumour-draining lymph node in immune evasion by retroperitoneal sarc
Join us this July as we raise awareness for one of Australia's rarest cancers!
This year's Sarcoma Awareness Month will focus on Harnessing the full potential of real-world evidence in Sarcoma - Using the ANZSA National Sarcoma database to complement clinical trials. The topic focuses on the use of the national sarcoma database to address research questions that otherwise cannot be answered by conventional clinical trials.
A new study published in Science Magazine has generated a comprehensive map of how the inheritance of genes may impact families affected by sarcoma. This research will lead to improved early detection of the cancer and potentially improving survival for patients
ANZSA is the proud funder of the MYTH Study currently being conducted at the Chris O’Brien Life House. The MYTH Study (Methotrexate for AYAs in The Home for adolescent and young adult (AYA) osteosarcoma patients) aims to give patients the option of treatment out of hospital and hopes to explore their perspective on the advantages and disadvantages of having treatment in this manner.